Transitional—fee waivers in relation to certain designations

Current

(1)

This regulation applies in relation to a designation of a medicine, vaccine or in vivo diagnostic agent as an orphan drug if the designation is in force under regulation 54 or 55.

(2)

The medicine, vaccine or in vivo diagnostic agent is taken to be a designated orphan drug for the purposes of the following provisions:

(a)

paragraphs 45(12)(c) and (d);

(b)

paragraph 46(2)(g);

(c)

items 1 to 2B in Part 1 of Schedule 3;

(d)

Part 3 of Schedule 3.

This Act’s bill:Explanatory statement

Research tools for this sectionSubscription

Cited by Analyse Interrogate History Equivalents

The statute text is free to read above. View subscription options to unlock the case-law research tools for each provision.

56 Transitional—fee waivers in relation to certain designations